Clinical Trials

42 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT01374841 2023-06-28

Hematopoietic Cell Transplantation for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors

20 enrolled

Hematologic Neoplasms

NCT05576532 2023-06-28

Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia

30 enrolled

Leukemia, Lymphoma, Recurrence, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

NCT02396043 2023-06-18

Modified BFM-95 Regimen as First-Line Chemotherapy in Adults With T- Lymphoblastic Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05821738 2023-05-09

Avapritinib in CBF-AML With KIT Mutations

Core Binding Factor Acute Myeloid Leukemia

NCT05252403 2023-05-06

Residual Disease Driven Strategy for CARCIK (CD19) in Adults/Pediatric BCP-ALL

35 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05823714 2023-04-21

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

70 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT03883087 2023-04-03

A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Chronic Phase With T315I Mutation

41 enrolled

Leukemia, Myeloid, Chronic-Phase

NCT04749355 2023-03-09

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS

40 enrolled

Recurrence, Leukemia, Myeloid, Acute

NCT04688021 2023-02-21

A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.

46 enrolled

Graft vs Host Disease, Leukemia

NCT02047578 2023-02-06

Targeted Busulfan, Fludarabine, Etoposide Conditioning Regimen for HSCT in Childhood and Adolescent ALL.

38 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05376852 2022-12-08

Case-Only

40 enrolled

Leukemia, Myeloid, Accelerated Phase

NCT05638763 2022-12-06

Cytochrome P450 Inhibition to Decrease Dosage of Dasatinib for Chronic Myelogenous Leukemia

15 enrolled

Leukemia, Myeloid, Chronic-Phase

NCT05291390 2022-11-29

Pyronaridine in Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML)

200 enrolled

Leukemia, Neoplasms, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03460522 2022-11-02

Inotuzumab Ozogamicin and Conventional Chemotherapy In Patients Aged 56 Years and Older With ALL

65 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05413356 2022-10-19

Ruxolitinib for Newly Diagnosed Bronchiolitis Obliterans Syndrome

Bronchiolitis Obliterans Syndrome, Hematologic Neoplasms

NCT04689815 2022-10-04

Oral Arsenic Trioxide for NPM1-mutated AML

Leukemia, Myeloid, Acute

NCT03280160 2022-09-16

Protocol GELLC-7: Ibrutinib Followed by Ibrutinib Consolidation in Combination With Ofatumumab

84 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04248595 2022-09-08

Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML

100 enrolled

Leukemia, Myeloid, Acute

NCT05362942 2022-05-05

Combination of Venetoclax, Hypomethylation Agent and Low-dose Cytarabine as a Salvage Therapy for Acute Myeloid Leukemia

52 enrolled

Leukemia, Myeloid, Acute, Neoplasm, Residual

NCT05330364 2022-04-29

Study of Chidamide Combined With Cladribine in Refractory/Relapsed Acute Myeloid Leukemia

31 enrolled

Leukemia, Myeloid, Acute

NCT05322733 2022-04-19

Orelabrutinib and Obinutuzumab Plus FC Regimen in Treating Newly Diagnosed CLL/SLL

25 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05287984 2022-03-31

ZFCR/ZBR

63 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT04867928 2022-03-16

Venetoclax and Azacitidine for the Management of Molecular Relapse/Progression in Adult NPM1-mutated Acute Myeloid Leukemia

35 enrolled

Leukemia, Myeloid, Acute

NCT03610438 2022-01-04

ALL2418

76 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02071901 2021-12-01

Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy

31 enrolled 14 charts

Congenital Abnormalities, Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Basophilic, Acute, Leukemia, Eosinophilic, Acute, Leukemia, Myelomonocytic, Acute

NCT04752527 2021-11-15

Individualized Induction Therapy for Non-elderly Acute Myeloid Leukemia Patients With Adverse Risk Features

42 enrolled

Leukemia, Myeloid, Acute

NCT05084027 2021-10-27

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

Hematologic Neoplasms

NCT03146468 2021-09-23

NIVALLO

14 enrolled

Hematologic Neoplasms

NCT00558519 2021-08-18

Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

318 enrolled 9 charts

Leukemia

NCT04906031 2021-06-09

Sodium Stibogluconate in the MDS/AML With One of the 65 Defined p53 Mutations

5 enrolled

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04069208 2021-06-08

IA14 Induction in Young Acute Myeloid Leukemia

42 enrolled

Leukemia, Myeloid, Acute

NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

102 enrolled 12 charts

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

NCT04904237 2021-06-01

Aza-Ven Followed by Reduced Toxicity Conditioning Regimen (MBF) as Salvage Therapy for Refractory AML.

23 enrolled

Leukemia, Myeloid, Acute

NCT03080766 2021-04-28

The Use of Decitabine as Induction Therapy for Acute Myeloid Leukemia With Complex and/or Monosomal Karyotype

20 enrolled

Leukemia, Myeloid, Acute

NCT02124174 2021-04-26

Vidaza and Valproic Acid Post Allogeneic Transplant for High Risk AML and MDS

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT04824924 2021-04-01

A Phase 2 Study of Venetoclax in Combination With Low-dose HHT, G-CSF, and AZA as First-line Treatment for Newly Diagnosed Elderly AML Patients Unfit for Intensive Chemotherapy

100 enrolled

Leukemia, Myeloid, Acute

NCT04747002 2021-03-03

Investigator-initiated Clinical Trial (Phase II) of Cancer Vaccine "Dainippon Sumitomo Phama(DSP)-7888" for Acute Myeloid Leukemia Patients.

100 enrolled

Acute Myeloid Leukemia in Remission

NCT04709731 2021-02-03

CarPAs

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04254640 2020-12-17

Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML

34 enrolled